<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04872946</url>
  </required_header>
  <id_info>
    <org_study_id>008</org_study_id>
    <nct_id>NCT04872946</nct_id>
  </id_info>
  <brief_title>Topical and Oral Regimen for Skin Health</brief_title>
  <official_title>Topical and Oral Regimen for Skin Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integrative Skin Science and Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Arbonne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Integrative Skin Science and Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to assess how oral supplementation with Inner Calm and&#xD;
      the use of topical Super Calm can affect the appearance of skin and inner wellness, such as&#xD;
      redness, skin sensitivity, and reactionary skin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The landscape for skin health has expanded past a focused use of topicals to incorporate the&#xD;
      use of supplementation. Notable examples include the ingestion of carotenoids and&#xD;
      beta-carotene to augment skin antioxidant status or the role of diet on different skin&#xD;
      conditions. The role of this investigation is to define how Inner Calm (oral supplementation)&#xD;
      may promote healthier skin and how this may work in synergy with Super Calm (topical&#xD;
      supplementation).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 26, 2019</start_date>
  <completion_date type="Actual">May 7, 2020</completion_date>
  <primary_completion_date type="Actual">May 7, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in appearance of facial redness</measure>
    <time_frame>8 weeks</time_frame>
    <description>Photographic image analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in appearance of facial pigmentation</measure>
    <time_frame>8 weeks</time_frame>
    <description>Photographic image analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in appearance of facial redness before and after treatment</measure>
    <time_frame>8 weeks</time_frame>
    <description>SkinColorCatch colorimeter RGB range: 25-246 per channel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective report of skin reactivity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Topical Clinical Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective report of sleep quality and quantity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pittsburg Sleep Quality Index survey (PSQI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective report of mood and energy</measure>
    <time_frame>8 weeks</time_frame>
    <description>Abbreviated Profile of Mood States Survey (POMS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective report of calmness of mind</measure>
    <time_frame>8 weeks</time_frame>
    <description>Inner and Outer Calm Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective report of calmness of skin</measure>
    <time_frame>8 weeks</time_frame>
    <description>Inner and Outer Calm Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in appearance of facial redness</measure>
    <time_frame>4 weeks</time_frame>
    <description>Photographic image analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in appearance of facial pigmentation</measure>
    <time_frame>4 weeks</time_frame>
    <description>Photographic image analysis</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Skin Abnormalities</condition>
  <arm_group>
    <arm_group_label>InnerCalm+skin care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An oral supplement and topical agent will be assigned.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>InnerCalm only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An oral supplement will be assigned.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Skincare Only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A topical agent only will be assigned.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tea</intervention_name>
    <description>Ashwagandha(Withania somnifera) root and leaf extract (32% Withania Oligosaccharides, 10% Withanolide Glycosides, 0.5% Withaferin A) 125 mg Saffron(Crocus Sativus) stigmas extract (3.48% Crocin and 0.03% Safranal) 28mg</description>
    <arm_group_label>InnerCalm only</arm_group_label>
    <arm_group_label>InnerCalm+skin care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Serum</intervention_name>
    <description>Aqua/Water/Eau, Glycerin, Propanediol, Diheptyl Succinate, Caprylic/Capric Triglyceride, Lactococcus Ferment Lysate, Sorbitol, Dimethicone, Steareth-21, Octyldodecyl Neopentanoate, Sodium Polyacrylate, Steareth-2, Caprylyl Glycol, Hydrogenated Polydecene, Trideceth-6, Octyldodecanol, Panthenol, Sodium PCA, Azelaic Acid, Bisabolol, Capryloyl Glycerin/Sebacic Acid Copolymer, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Caprylhydroxamic Acid, Phytic Acid, Aminomethyl Propanol, Lactic Acid, Sodium Chloride, Phenoxyethanol, Sodium Benzoate.</description>
    <arm_group_label>InnerCalm+skin care</arm_group_label>
    <arm_group_label>Skincare Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moisturizer</intervention_name>
    <description>Aqua/Water/Eau, Glycerin, Diisopropyl Dimer Dilinoleate, Coco-Caprylate, Lactococcus Ferment Lysate, Myristyl Myristate, Dimethicone, Propanediol, Behenyl Alcohol, Glyceryl Stearate SE, Potassium Cetyl Phosphate, Palmitic Acid, Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer, Myristyl Laurate, Caprylyl Glycol, Hydroxyethylcellulose, Myristic Acid, Tocopherol, Ethylhexylglycerin, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Helianthus Annuus (Sunflower) Seed Oil, Trisodium Ethylenediamine Disuccinate, Lactic Acid, Sodium Hydroxide, Sodium Phosphate, Disodium Phosphate, Sodium Chloride, t-Butyl Alcohol, Phenoxyethanol, Sodium Benzoate.</description>
    <arm_group_label>InnerCalm+skin care</arm_group_label>
    <arm_group_label>Skincare Only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women aged 18-55&#xD;
&#xD;
          -  Fitzpatrick skin type 1-4&#xD;
&#xD;
          -  Self-perception as sensitive skin&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Individuals who are not yet adults (infants, children, teenagers)&#xD;
&#xD;
          -  Pregnant or breast-feeding women&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Those who have used isotretinoin in the last 6 months&#xD;
&#xD;
          -  Those who have used products containing salicylic acid, beta hydroxyl acids or&#xD;
             vitamins A, C, or E or topical retinoids or topical depigmenting agents (such as&#xD;
             hydroquinone, kojic acid, azelaic acid, or others in opinion of the investigator) in&#xD;
             the last 14 days&#xD;
&#xD;
          -  Those who are currently smoking or have smoked within the past 3 years.&#xD;
&#xD;
          -  Those who have had a recent surgical or cosmetic procedure in the last 3 months that&#xD;
             can affect facial wrinkles, redness, or hyperpigmentation, such as botulinum toxin&#xD;
             injections, chemical peels, laser-based therapies to the face, or face lift surgeries&#xD;
&#xD;
          -  Subjects with known allergy to any of the components of Inner Calm or Skin Calm&#xD;
&#xD;
          -  Those that are unwilling to discontinue use of any other nutritional supplements&#xD;
             including antioxidants, herbs, or protein-based supplements for 2 weeks prior to and&#xD;
             during their participation.&#xD;
&#xD;
          -  Subjects with a diagnosis of acne&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raja K Sivamani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Integrative Skin Science and Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Integrative Skin Science and Research</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 9, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>skin</keyword>
  <keyword>dermatology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

